Thanks to a 4-year, $2.97 million grant from the National Institutes of Health (NIH), UT Southwestern now heads a consortium investigating why children and young…
COVID-19 has led to a wave of new rules and a new set of expectations involving clinical trials as research centers such as UT Southwestern…
UT Southwestern Medical Center researchers are investigating existing, available drugs that could potentially help treat mild to moderate COVID-19 cases. This move by the number…
UT Southwestern is on the move, taking on COVID-19 in a number of ways. Recently, Dallas Innovates showcased five core activities ongoing, including 1) convalescent…
University of Texas Southwestern Medical Center researchers have identified a potential COVID-19 treatment in preclinical research activity targeting COVID-19, and they are now making the…
Taysha Gene Therapies just emerged out of stealth mode with a $30 million seed round and a strategic partnership with UT Southwestern. The gene therapy-based spinoff…
Because delays or lags in the time it takes a clinical investigational site to activate a clinical trial can have a direct impact on the…
University of Texas Southwestern (UTSW) inked a collaborative research deal with Recombinetics (RCI) to identify key factors that improve the efficiency of generating interspecies chimera…
Using human lung cancer cells, UT Southwestern researchers have uncovered how cells in general modulate their energy consumption based on their surroundings and, furthermore, how…
UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combination that halts the growth of cancer cells that carry HER2 mutations. Patients with cancers…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
